Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Haoxi Health TechnologyHAO -13.51%21 EV-to-OCF is 1.13 as of Aug. 19, 2026, which is 6% above its 10-year median of 1.07. GuruFocus rates HAO with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 1,020 Media - Diversified companies, Haoxi Health Technology ranks better than 63.63% on this metric.
The historical rank and industry rank for Haoxi Health Technology's EV-to-OCF or its related term are showing as below:
HAO'
s EV-to-OCF Range Over the Past 10 Years
Min: -475.27 Med: 1.07 Max: 3.94
Current: 1.13
During the past 5 years, the highest EV-to-OCF of Haoxi Health Technology was 3.94. The lowest was -475.27. And the median was 1.07.
HAO's EV-to-OCF is ranked better than 63.63% of 1020
companies
in the Media - Diversified industry
Industry Median: 4.49
vs HAO: 1.13
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Haoxi Health Technology (NAS:HAO) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Haoxi Health Technology's PE Ratio (TTM) for today is calculated as:
Haoxi Health Technology's share price for today is $3.84.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Haoxi Health Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-283.544.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Advertising Agencies subindustry, Haoxi Health Technology's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haoxi Health Technology EV-to-OCF vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Haoxi Health Technology's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Haoxi Health Technology's EV-to-OCF falls into.
Haoxi Health Technology's current Enterprise Value is $-3.80 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Haoxi Health Technology's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $-3.38 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haoxi Health Technology (HAO) has a EV-to-OCF of 1.13 as of Aug. 19, 2026. This is near median its historical median of 1.07. According to the industry distribution chart, Haoxi Health Technology ranks #371 out of 1020 companies in the Media - Diversified industry, placing it in the top 36.4%.
Is Haoxi Health Technology's EV-to-OCF too high?
Haoxi Health Technology's current EV-to-OCF of 1.13 is near median its 10-year median of 1.07. The Media - Diversified industry median EV-to-OCF is 4.49. Haoxi Health Technology's value of 1.13 is 74.8% below this industry median. Based on the distribution chart, Haoxi Health Technology ranks #371 out of 1020 companies in the Media - Diversified industry, which is above the industry midpoint. Overall, Haoxi Health Technology has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Haoxi Health Technology's EV-to-OCF compare to BAOS and DBMM?
According to the Media - Diversified industry distribution chart, Haoxi Health Technology ranks #371 out of 1020 companies for EV-to-OCF. This puts Haoxi Health Technology in the upper half of its industry. The industry median EV-to-OCF is 4.49. Haoxi Health Technology's value of 1.13 is 74.8% below this benchmark. While the company's 10-year median is 1.07 vs. the industry median of 4.49, Haoxi Health Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Media - Diversified company?
The median EV-to-OCF among Media - Diversified companies is 4.49, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haoxi Health Technology's current EV-to-OCF of 1.13 is 74.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Media - Diversified industry, the median EV-to-OCF is 4.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haoxi Health Technology's current EV-to-OCF is 1.13, which is near median its own 10-year median of 1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haoxi Health Technology stock overvalued right now?
Haoxi Health Technology (HAO) has a current EV-to-OCF of 1.13. The current EV-to-OCF is 1.13, which is near median its 10-year median of 1.07 and 74.8% below the Media - Diversified industry median of 4.49. Haoxi Health Technology's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Haoxi Health Technology (HAO), the current EV-to-OCF is 1.13 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. The company offers services that include planning, producing, placing, and optimizing online ads especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms. It places advertisements on popular digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo through media partners. Revenue is generated by providing comprehensive online marketing solutions. The company's operations center on digital advertising via mainstream video and social media channels in the Chinese market.
21GF Score
Get the complete analysis for HAO
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAO has been successfully added to your 
